Gene Therapy for Cardiomyocyte Renewal: Cell Cycle, a Potential Therapeutic Target

Area of Science:

• Cardiovascular Research
• Regenerative Medicine
• Gene Therapy

Background:

• Heart disease remains a leading global cause of mortality despite advances in treatment.
• Limited proliferation of adult cardiomyocytes hinders natural heart repair after injury.
• Gene therapy is a key tool for understanding myocardial infarction and cardiomyocyte loss.

Purpose of the Study:

• To review gene therapeutic targets for reactivating cardiomyocyte proliferation.
• To explore strategies for promoting adult cardiomyocyte renewal.
• To summarize gene delivery vectors and challenges in clinical translation.

Main Methods:

• Review of current gene therapeutic targets including cell cycle regulators, transcription factors, and microRNAs.
• Summary of gene delivery vectors employed in cardiac research.
• Analysis of challenges and future directions for clinical application.

Main Results:

• Identified key gene targets (cell cycle regulators, transcription factors, microRNAs, signal transduction pathways) for cardiomyocyte proliferation.
• Cataloged various gene delivery vectors used in preclinical cardiac studies.
• Highlighted significant hurdles in translating gene therapy for cardiac regeneration to clinical practice.

Conclusions:

• Re-activating cardiomyocyte proliferation via gene therapy presents a promising regenerative strategy for heart disease.
• Further research and overcoming delivery challenges are crucial for successful clinical translation.
• Targeting cell cycle regulators and other factors holds potential for heart repair.